Advertisement
The team behind the vaccine from Oxford and AstraZeneca is undertaking feasibility studies to reconfigure the technology, the report said citing confirmation from Oxford University.
The scientists were working on estimating how quickly they could reconfigure their ChAdOx vaccine platform